Jim Plante has developed a well-deserved reputation as one of today’s leaders in investment and entrepreneurship in the field of biotechnology. With over 25 years of success in the field, he has played an integral role in establishing biotech companies that offer innovative products and services. Read on to find out a little bit about his professional history below.
Mr. Plante began his education by obtaining a degree in Electrical Engineering. He graduated from Southern Illinois University and began his career as an investor and entrepreneur, focusing on the technology industry and biotech in particular.
Early Work History
At the age of 30, Mr. Plante played a key role in acquiring Beltronics, a well-known provider global provider of high-performance millimeter wave safety systems. As the company’s interim president, Plante turned Beltronics around by helping to launch an innovative product line.
This industry leader also played an integral role in launching the first multigigabit capacity communications links as the CEO of E-Band Communications. He then went on to found SmartDrive Systems, a company that was responsible for developing the SAAS commercial vehicle safety program, in 2004. SmartDrive’s GPS, audio, and video-integrated platform offered drivers one of the most effective real-time monitoring systems of its day.
In 2008, Plante helped to found Pathway Genomics. He also served as a chairman of the company’s board and its CEO. Under his guidance, the company began the production of state-of-the-art genetic testing devices that led the field in terms of genetic testing.
Plante’s motivation to found Pathway Genomics hearkens back to his early life, in which his father suffered from polycystic kidney disease. At the time, there were not adequate testing measures in place for diagnosing his father’s disease and he died as a result.
Upon discovering that he suffered from the same genetically inherited disorder, Plante had a kidney transplant and decided to devote his life to helping others get the affordable and effective genetic testing they need to receive an early diagnosis of this and other genetic diseases and disorders. His work with Pathway Genomics has helped doctors prevent disease and develop personalized treatment plants that ensure the best possible patient outcomes.